Genetic susceptibility to breast cancer.

Abstract excerpt

Deleterious mutations in two breast and ovarian cancer susceptibility genes, BRCA1 and BRCA2 have been identified in breast and ovarian cancer families. Women with a BRCA1 or BRCA2 mutation are candidates for additional risk reduction measures such as intensive screening, prophylactic surgery or chemoprevention. Additional susceptibility genes have been identified, including PTEN, ATM, TP53, CHEK2, CASP8, PBRL...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Genetic Testing
• Share to Risk Assessment
• Share to BRCA1 Protein